These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 27155683)

  • 61. The role of Helicobacter pylori in peptic ulcer disease.
    O'Connor HJ
    Scand J Gastroenterol Suppl; 1994; 201():11-5. PubMed ID: 8047817
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Current therapy of Helicobacter pylori infection].
    Labenz J; Stolte M
    Leber Magen Darm; 1994 Feb; 24(1):5-9. PubMed ID: 8145628
    [No Abstract]   [Full Text] [Related]  

  • 63. Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains.
    Molina-Infante J; Pazos-Pacheco C; Vinagre-Rodriguez G; Perez-Gallardo B; Dueñas-Sadornil C; Hernandez-Alonso M; Gonzalez-Garcia G; Mateos-Rodriguez JM; Fernandez-Bermejo M; Gisbert JP
    Helicobacter; 2012 Aug; 17(4):269-76. PubMed ID: 22759326
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The actions of bismuth in the treatment of Helicobacter pylori infections: an update.
    Ge R; Chen Z; Zhou Q
    Metallomics; 2012 Mar; 4(3):239-43. PubMed ID: 22358069
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Characteristics of the effects of de-nol on the course of erosive-ulcerative lesions of the esophagus, stomach and duodenum associated with Helicobacter pylori].
    Grebenev AL; Miagkova LP; Golochevskaia VS; Lapina TL; Sklianskaia OA
    Klin Med (Mosk); 1995; 73(2):34-7. PubMed ID: 7609414
    [No Abstract]   [Full Text] [Related]  

  • 66. The treatment of Helicobacter pylori infection in the management of peptic ulcer disease.
    Walsh JH; Peterson WL
    N Engl J Med; 1995 Oct; 333(15):984-91. PubMed ID: 7666920
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Barry Marshall, MD: H pylori 35 Years Later.
    Abbasi J
    JAMA; 2017 Apr; 317(14):1400-1402. PubMed ID: 28399250
    [No Abstract]   [Full Text] [Related]  

  • 68. [The treatment characteristics of patients with peptic ulcer infected with Helicobacter pylori].
    Kharchenko NV
    Lik Sprava; 1999 Mar; (2):70-4. PubMed ID: 10424047
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparison table: Drugs for GERD and peptic ulcer disease.
    Med Lett Drugs Ther; 2018 Jan; 60(1538):e16-e18. PubMed ID: 29309400
    [No Abstract]   [Full Text] [Related]  

  • 70. Helicobacter pylori: a human pathogen.
    Murray L; Harvey I
    Lancet; 1995 Jun; 345(8964):1579-80. PubMed ID: 7791471
    [No Abstract]   [Full Text] [Related]  

  • 71. Good bugs and bad bugs: indications and therapies for Helicobacter pylori eradication.
    Kuipers EJ; Janssen MJ; de Boer WA
    Curr Opin Pharmacol; 2003 Oct; 3(5):480-5. PubMed ID: 14559092
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Helicobacter pylori eradication in elderly patients: can we assume that a bismuth-based therapy is effective as in young people?
    Mladenova I
    Panminerva Med; 2022 Jun; 64(2):289. PubMed ID: 35815768
    [No Abstract]   [Full Text] [Related]  

  • 73. H. pylori and ulcers.
    McGuffey EC
    Am Pharm; 1994 Jul; NS34(7):21. PubMed ID: 8085532
    [No Abstract]   [Full Text] [Related]  

  • 74. Eradication of Helicobacter pylori Infection.
    Marcus EA; Sachs G; Scott DR
    Curr Gastroenterol Rep; 2016 Jul; 18(7):33. PubMed ID: 27177639
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Single-capsule bismuth quadruple therapy: preferable at the moment, but what should be next?
    Suzuki H; Mori H
    United European Gastroenterol J; 2021 Feb; 9(1):7-8. PubMed ID: 33210981
    [No Abstract]   [Full Text] [Related]  

  • 76. Clarithromycin resistance in Helicobacter pylori: implications for therapy.
    Fujioka T
    J Gastroenterol; 2000; 35(1):69-70. PubMed ID: 10632546
    [No Abstract]   [Full Text] [Related]  

  • 77. Eradication of
    Zhang Q; Wu W; Zhang J; Xia X
    Nanomedicine (Lond); 2020 Feb; 15(5):527-542. PubMed ID: 32028847
    [No Abstract]   [Full Text] [Related]  

  • 78. Significance of a tetracycline and Pepto-Bismol interaction in the management of Helicobacter pylori-induced peptic ulcer disease.
    Tkach CL; Ariano RE
    Ann Pharmacother; 1998 Mar; 32(3):387. PubMed ID: 9533072
    [No Abstract]   [Full Text] [Related]  

  • 79. You're the flight surgeon. H. pylori positive peptic ulcer disease.
    Winkler A
    Aviat Space Environ Med; 2010 Oct; 81(10):974-5. PubMed ID: 20922892
    [No Abstract]   [Full Text] [Related]  

  • 80. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.
    Malfertheiner P; Megraud F; O'Morain CA; Gisbert JP; Kuipers EJ; Axon AT; Bazzoli F; Gasbarrini A; Atherton J; Graham DY; Hunt R; Moayyedi P; Rokkas T; Rugge M; Selgrad M; Suerbaum S; Sugano K; El-Omar EM;
    Gut; 2017 Jan; 66(1):6-30. PubMed ID: 27707777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.